MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma
- PMID: 34647653
- PMCID: PMC9292973
- DOI: 10.1002/hed.26894
MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma
Abstract
Background: Patients with intestinal-type sinonasal adenocarcinoma (ITAC) have an unfavorable prognosis, and new diagnostic and therapeutic approaches are needed to improve clinical management.
Methods: Next-generation sequencing-based miRNome analysis was performed on 43 ITAC patients who underwent surgical resection, and microRNA (miRNA) data were obtained from 35 cases. Four miRNAs were identified, and their expression levels were detected by reverse-transcription quantitative polymerase chain reaction and related to the relevant patient outcome. Overall survival and disease-free survival rates were evaluated through the Kaplan-Meier method and log-rank test, and multivariate analysis was performed by means of Cox proportional hazard analysis.
Results: High levels of miR-205 and miR-34c/miR-449 cluster expression were associated with an increased recurrence risk and, therefore, a worse prognosis. Multivariate analysis confirmed that miR-205 and miR-449 were significant prognostic predictors.
Conclusions: A high expression of miR-205 and miR-449 is independent predictors of poor survival for ITAC patients.
Keywords: biomarkers; ethmoid sinus; intestinal-type sinonasal adenocarcinoma (ITAC); miRNAs; miRNome.
© 2021 The Authors. Head & Neck published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures






Similar articles
-
Deregulation of selected microRNAs in sinonasal carcinoma: Value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma.Head Neck. 2017 Dec;39(12):2528-2536. doi: 10.1002/hed.24930. Epub 2017 Sep 28. Head Neck. 2017. PMID: 28960576
-
Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.Diagn Pathol. 2015 Jul 12;10:99. doi: 10.1186/s13000-015-0339-4. Diagn Pathol. 2015. PMID: 26170125 Free PMC article.
-
[Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].Ann Otolaryngol Chir Cervicofac. 2009 Sep;126(4):175-81. doi: 10.1016/j.aorl.2009.06.001. Epub 2009 Jul 9. Ann Otolaryngol Chir Cervicofac. 2009. PMID: 19591973 French.
-
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.Oncotarget. 2016 Dec 6;7(49):81281-81291. doi: 10.18632/oncotarget.12832. Oncotarget. 2016. PMID: 27793030 Free PMC article. Review.
-
Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC.Cancers (Basel). 2023 Jun 15;15(12):3201. doi: 10.3390/cancers15123201. Cancers (Basel). 2023. PMID: 37370810 Free PMC article. Review.
Cited by
-
AGO2-RIP-Seq reveals miR-34/miR-449 cluster targetome in sinonasal cancers.PLoS One. 2024 Jan 12;19(1):e0295997. doi: 10.1371/journal.pone.0295997. eCollection 2024. PLoS One. 2024. PMID: 38215077 Free PMC article.
-
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer.Mol Med. 2025 Mar 25;31(1):116. doi: 10.1186/s10020-025-01163-z. Mol Med. 2025. PMID: 40133809 Free PMC article.
-
Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis.Pharm Biol. 2023 Dec;61(1):868-877. doi: 10.1080/13880209.2023.2204879. Pharm Biol. 2023. PMID: 37300283 Free PMC article.
-
The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside.Genes (Basel). 2025 Feb 28;16(3):295. doi: 10.3390/genes16030295. Genes (Basel). 2025. PMID: 40149447 Free PMC article. Review.
-
LncRNA EGFR‑AS1 promotes lung cancer cell proliferation, invasion and metastasis via regulation of miR‑449a/HDAC1.Exp Ther Med. 2024 Dec 3;29(2):27. doi: 10.3892/etm.2024.12777. eCollection 2025 Feb. Exp Ther Med. 2024. PMID: 39720671 Free PMC article.
References
-
- Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population‐based data. Head Neck. 2012;34:877‐885. - PubMed
-
- Kilic S, Samarrai R, Kilic SS, Mikhael M, Baredes S, Eloy JA. Incidence and survival of sinonasal adenocarcinoma by site and histologic subtype. Acta Otolaryngol. 2018;138(4):415‐421. - PubMed
-
- Weber AL, Stanton AC. Malignant tumors of the paranasal sinuses: radiologic, clinical, and histopathologic evaluation of 200 cases. Head Neck Surg. 1984;6(3):761‐776. - PubMed
-
- D'Aguillo CM, Kanumuri VV, Khan MN, et al. Demographics and survival trends of sinonasal adenocarcinoma from 1973 to 2019. Int Forum Allergy Rhinol. 2014;4:771‐776. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources